These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16942658)

  • 21. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
    Gutiérrez S; Guillemi S; Jahnke N; Montessori V; Harrigan PR; Montaner JS
    Clin Infect Dis; 2008 Feb; 46(3):e28-30. PubMed ID: 18181733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
    Liaw YF; Hsieh SY; Chien RN; Chen TJ; Sheen IS; Chu CM
    Prog Clin Biol Res; 1993; 382():229-34. PubMed ID: 8502686
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.
    Raffa G; Maimone S; Cargnel A; Santantonio T; Antonucci G; Massari M; Schiavini M; Caccamo G; Pollicino T; Raimondo G
    AIDS; 2007 Oct; 21(16):2171-5. PubMed ID: 18090043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.
    Ramia S; Mokhbat J; Ramlawi F; El-Zaatari M
    Int J STD AIDS; 2008 Mar; 19(3):197-9. PubMed ID: 18397562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hepatitis due to HBV-HDV coinfection.
    Zar T; Sharar Z; Mughal M; McClintock C
    Conn Med; 2001 Nov; 65(11):649-52. PubMed ID: 11766551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does HBeAg minus HBV modify the course of HDV superinfection?
    Brunetto MR; Oliveri F; Baldi M; Chiaberge E; Smedile A; Stemler M; Will H; Rizzetto M; Verme G; Bonino F
    Prog Clin Biol Res; 1991; 364():211-6. PubMed ID: 2020699
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of HIV infection on hepatitis B virus infection in homosexual patients].
    Favre O; Heyraud JP; Chossegros P; Retornaz G; Ouzan D; Neyrat M; Trépo C
    Gastroenterol Clin Biol; 1989; 13(8-9):696-700. PubMed ID: 2806805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre.
    Das K; Ali H; Mahmood T; Munir SM; Ahmed T; Farooq MU
    J Ayub Med Coll Abbottabad; 2008; 20(2):39-42. PubMed ID: 19385455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenofovir helps beat hepatitis B.
    TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
    [No Abstract]   [Full Text] [Related]  

  • 38. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.
    Nüesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B
    AIDS; 2008 Jan; 22(1):152-4. PubMed ID: 18090405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.